Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data…more
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data…more
Latest RNS from Diaceutics PLC
- notice_of_resultsNotice of Results & Presentations
- product_launchDiaceutics and PCC launch NGS Concordance Study
Analyst consensus: Buy
As of 20 Sept 2026, 5 analysts rate Diaceutics PLC a Buy, with 100% buy ratings and a mean price target of 213p (range 185p–235p), +25% vs the current price.